1. Home
  2. ASYS vs LXEO Comparison

ASYS vs LXEO Comparison

Compare ASYS & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amtech Systems Inc.

ASYS

Amtech Systems Inc.

N/A

Current Price

$16.47

Market Cap

312.2M

Sector

Technology

ML Signal

N/A

Logo Lexeo Therapeutics Inc.

LXEO

Lexeo Therapeutics Inc.

N/A

Current Price

$3.23

Market Cap

348.7M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ASYS
LXEO
Founded
1981
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
312.2M
348.7M
IPO Year
2006
2023

Fundamental Metrics

Financial Performance
Metric
ASYS
LXEO
Price
$16.47
$3.23
Analyst Decision
Buy
Strong Buy
Analyst Count
2
10
Target Price
★ $22.50
$20.30
AVG Volume (30 Days)
213.7K
★ 1.7M
Earning Date
08-05-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 39.81
EPS
★ 0.19
N/A
Revenue
★ $79,364,000.00
$654,000.00
Revenue This Year
$8.11
N/A
Revenue Next Year
$39.86
N/A
P/E Ratio
$85.32
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$6.75
$2.98
52 Week High
$25.71
$10.99

Technical Indicators

Market Signals
Indicator
ASYS
LXEO
Relative Strength Index (RSI) 53.16 30.76
Support Level $15.89 $2.98
Resistance Level $17.57 $3.68
Average True Range (ATR) 0.63 0.28
MACD 0.09 -0.01
Stochastic Oscillator 49.00 17.41

Price Performance

Historical Comparison
ASYS
LXEO

About ASYS Amtech Systems Inc.

Amtech Systems Inc provides equipment, consumables and services for semiconductor device packaging, wafer production and device fabrication. Its products are used to fabricate and package GPUs for AI applications, SiC and Si power devices, and other optical, analog and digital devices, and are sold to semiconductor packaging, electronic assembly and device fabrication companies. It operates through two segments: Thermal Processing Solutions, which includes conveyorized reflow equipment, high-temperature conveyorized furnaces and diffusion furnaces with maximum revenue; and Semiconductor Fabrication Solutions, which includes consumables, equipment and services for wafer polishing, dicing and cleaning. The majority of revenue is derived from the United States.

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases. The company is advancing a portfolio of programs focused on conditions such as Friedreich ataxia, cardiomyopathy, plakophilin-2, or PKP2, and arrhythmogenic cardiomyopathy, with its lead candidates including LX2006 and LX2020. Its therapies utilize AAV-based vectors designed to deliver functional genes to cardiac cells to restore normal function and address high unmet medical needs.

Share on Social Networks: